Cytokine gene expression on glioma cell lines and specimens.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

16 citing papers in PubMed, 29 citations in OpenAlex.

1. Depletion of eukaryotic initiation factor 5B (eIF5B) reprograms the cellular transcriptome and leads to activation of endoplasmic reticulum (ER) stress and c-Jun N-terminal kinase (JNK).Cell stress & chaperones · 2021
   Article
2. Tumour-derived CSF2/granulocyte macrophage colony stimulating factor controls myeloid cell accumulation and progression of gliomas.British journal of cancer · 2020
   Article
3. RelB acts as a molecular switch driving chronic inflammation in glioblastoma multiforme.Oncogenesis · 2019
   Article
4. Pediatric glioblastoma cells inhibit neurogenesis and promote astrogenesis, phenotypic transformation and migration of human neural progenitor cells within cocultures.Experimental cell research · 2018
   Article
5. Pre-exposure of human adipose mesenchymal stem cells to soluble factors enhances their homing to brain cancer.Stem cells translational medicine · 2015
   Article
6. Interleukin-1β promotes hypoxia-induced apoptosis of glioblastoma cells by inhibiting hypoxia-inducible factor-1 mediated adrenomedullin production.Cell death & disease · 2014
   Article
7. Immunomodulatory nature and site specific affinity of mesenchymal stem cells: a hope in cell therapy.Advanced pharmaceutical bulletin · 2014
   Review
8. iNOS: a potential therapeutic target for malignant glioma.Current molecular medicine · 2013
   Review
9. Umbilical cord blood-derived mesenchymal stem cells inhibit, but adipose tissue-derived mesenchymal stem cells promote, glioblastoma multiforme proliferation.Stem cells and development · 2013
   Article
10. Interleukins in glioblastoma pathophysiology: implications for therapy.British journal of pharmacology · 2013
    Review
11. In silico experimentation of glioma microenvironment development and anti-tumor therapy.PLoS computational biology · 2012
    Article
12. STAT3 regulation of glioblastoma pathogenesis.Current molecular medicine · 2009
    Review
13. Deregulation of a STAT3-interleukin 8 signaling pathway promotes human glioblastoma cell proliferation and invasiveness.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2008
    Article
14. Increased efficacy of an interleukin-12-secreting herpes simplex virus in a syngeneic intracranial murine glioma model.Neuro-oncology · 2005
    Article
15. Cell kinetic analysis in recurrent neuro-epithelial tumours.Acta neurochirurgica · 1996
    Article
16. Growth inhibition of human glioma cells modulated by retrovirus gene transfection with antisense IL-8.Journal of neuro-oncology · 1995
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

4 authors at 2 institutions in 1 country.

Funding

No grant is acknowledged in the PubMed record.

Abstract

Indexed as